Funds holding Genmab A/S
ISIN US3723032062 · Denmark · LEI 529900MTJPDPE4MHJ122
- Fund holders
- 51
- Of which ETFs
- 14 37 other funds
- Value held
- ≈ 320.9M $ 320.7M $ · 173.3K €
Other securities from the same issuer : Genmab A/S (DK0010272202)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| iShares Biotechnology ETF iShares Trust | 3,555,098 | 95.4M $ | 1.17 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2,354,019 | 63.2M $ | 2.78 % | as of Mar 31, 2026 ↗ |
| AB LARGE CAP GROWTH FUND INC AB LARGE CAP GROWTH FUND INC | 1,848,858 | 49M $ | 0.21 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 520,700 | 13.8M $ | 0.30 % | as of Apr 30, 2026 ↗ |
| Avantis International Equity ETF American Century ETF Trust | 447,322 | 13.2M $ | 0.09 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 350,000 | 9.3M $ | 0.32 % | as of Apr 30, 2026 ↗ |
| Tax-Managed U.S. Large Cap Fund RUSSELL INVESTMENT CO | 342,344 | 9.1M $ | 0.08 % | as of Apr 30, 2026 ↗ |
| Federated Hermes International Leaders Fund Federated Hermes World Investment Series, Inc. | 258,730 | 7.6M $ | 0.44 % | as of Feb 28, 2026 ↗ |
| Mercer Non-US Core Equity Fund Mercer Funds | 179,676 | 4.8M $ | 0.11 % | as of Mar 31, 2026 ↗ |
| AB Growth Fund AB PORTFOLIOS | 179,130 | 4.8M $ | 0.31 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 169,724 | 5M $ | 3.13 % | as of Feb 28, 2026 ↗ |
| LVIP AllianceBernstein Large Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 163,812 | 4.4M $ | 0.30 % | as of Mar 31, 2026 ↗ |
| SA AB Growth Portfolio SUNAMERICA SERIES TRUST | 161,398 | 4.3M $ | 0.24 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced International ETF Fidelity Covington Trust | 156,871 | 4.2M $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Timothy Plan International Fund TIMOTHY PLAN | 137,000 | 3.7M $ | 1.84 % | as of Mar 31, 2026 ↗ |
| AB Large Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 105,277 | 2.8M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| U.S. Strategic Equity Fund RUSSELL INVESTMENT CO | 104,293 | 2.8M $ | 0.09 % | as of Apr 30, 2026 ↗ |
| SIMT Large Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 82,643 | 2.2M $ | 0.16 % | as of Mar 31, 2026 ↗ |
| LVIP Blended Large Cap Growth Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 79,399 | 2.1M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| First Trust Nasdaq BuyWrite Income ETF First Trust Exchange-Traded Fund VI | 73,468 | 2M $ | 0.25 % | as of Mar 31, 2026 ↗ |
| SIMT Large Cap Value Fund SEI INSTITUTIONAL MANAGED TRUST | 60,494 | 1.6M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| SIMT Tax-Managed Large Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 50,811 | 1.4M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Quantified Global Fund Advisors Preferred Trust | 50,720 | 1.4M $ | 4.89 % | as of Mar 31, 2026 ↗ |
| Multi-Manager International Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 47,510 | 1.4M $ | 0.04 % | as of Feb 28, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 42,572 | 1.3M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers International Fund Fidelity Rutland Square Trust II | 38,964 | 1.1M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| SIIT LARGE CAP DISCIPLINED EQUITY FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 36,630 | 1.1M $ | 0.08 % | as of Feb 28, 2026 ↗ |
| Avantis International Equity Fund American Century ETF Trust | 35,483 | 1M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 32,836 | 966.7K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 30,853 | 827.8K $ | 1.83 % | as of Mar 31, 2026 ↗ |
| Virtus Small-Cap Fund Virtus Investment Trust | 27,495 | 737.7K $ | 0.69 % | as of Mar 31, 2026 ↗ |
| Alger Capital Appreciation Portfolio ALGER PORTFOLIOS | 24,849 | 666.7K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| U.S. Strategic Equity Fund RUSSELL INVESTMENT FUNDS | 22,592 | 606.1K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| EQ/International Core Managed Volatility Portfolio EQ Advisors Trust | 20,185 | 541.6K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Avantis International Large Cap Value ETF American Century ETF Trust | 18,225 | 536.5K $ | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 13,784 | 405.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Equity Income Fund RUSSELL INVESTMENT CO | 12,547 | 332.7K $ | 0.22 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 11,372 | 305.1K $ | 0.32 % | as of Mar 31, 2026 ↗ |
| Avantis Responsible International Equity ETF American Century ETF Trust | 8,571 | 252.3K $ | 0.06 % | as of Feb 28, 2026 ↗ |
| Large Company Growth Portfolio Wilshire Mutual Funds Inc | 7,044 | 189K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| PRAXIS INTERNATIONAL INDEX FUND Praxis Mutual Funds | 6,790 | 182.2K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,245 | 95.5K $ | 0.13 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,699 | 79.5K $ | 0.09 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,900 | 51K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| LARGE CAP INTERNATIONAL PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,009 | 26.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 931 | 25K $ | 1.10 % | as of Mar 31, 2026 ↗ |
| JPMorgan Healthcare Leaders ETF J.P. Morgan Exchange-Traded Fund Trust | 523 | 13.9K $ | 0.12 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 395 | 11.6K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Putnam PanAgora ESG International Equity ETF Putnam ETF Trust | 337 | 8.9K $ | 0.22 % | as of Apr 30, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 113.8K € | 3.10 % | as of Dec 31, 2025 ↗ | |
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / SYSTEMATIC VALUE INVESTING US MARKETS ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 59.5K € | 6.10 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / SYSTEMATIC VALUE INVESTING US MARKETS ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 6.10 % | as of Dec 31, 2025 ↗ |
| Quantified Global Fund Advisors Preferred Trust | 4.89 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 3.13 % | as of Feb 28, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.10 % | as of Dec 31, 2025 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2.78 % | as of Mar 31, 2026 ↗ |
| Timothy Plan International Fund TIMOTHY PLAN | 1.84 % | as of Mar 31, 2026 ↗ |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 1.83 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1.17 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 1.10 % | as of Mar 31, 2026 ↗ |
| Virtus Small-Cap Fund Virtus Investment Trust | 0.69 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 49 | +2 | 11,881,128 | +6.6 % |
| 2026Q1 | 47 | +4 | 11,143,685 | +2.9 % |
| 2025Q4 | 43 | +11 | 10,831,671 | +60.6 % |
| 2025Q3 | 32 | -1 | 6,745,391 | -39.8 % |
| 2025Q2 | 33 | +1 | 11,211,665 | +0.4 % |
| 2025Q1 | 32 | +1 | 11,168,522 | -20.1 % |
| 2024Q4 | 31 | -4 | 13,969,535 | -2.7 % |
| 2024Q3 | 35 | +2 | 14,356,542 | +1.4 % |
| 2024Q2 | 33 | -6 | 14,151,517 | +23.9 % |
| 2024Q1 | 39 | -18 | 11,420,869 | -30.7 % |
| 2023Q4 | 57 | 16,476,802 |
Institutional managers
269 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Orbis Allan Gray Ltd | 12,925,578 | 346.8M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 9,557,149 | 294.4M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 7,967,836 | 213.8M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4,975,324 | 133.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,536,565 | 121.7M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 4,414,550 | 118.4M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 3,663,250 | 98.3M $ | as of Mar 31, 2026 |
| Harding Loevner LP | 3,231,601 | 86.7M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,462,000 | 66.1M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 2,461,342 | 66M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,339,432 | 62.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,184,701 | 58.6M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,251,590 | 33.6M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,193,145 | 32M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,077,471 | 28.9M $ | as of Mar 31, 2026 |
| FMR LLC | 1,011,726 | 27.1M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 950,534 | 25.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 931,259 | 25M $ | as of Mar 31, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | 862,301 | 23.1M $ | as of Mar 31, 2026 |
| Russell Investments Group, Ltd. | 797,068 | 21.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 792,293 | 21.3M $ | as of Mar 31, 2026 |
| Perpetual Ltd | 758,503 | 20.4M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 752,261 | 20.2M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 677,346 | 18.2M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 645,481 | 17.3M $ | as of Mar 31, 2026 |
Funds holding the debt of Genmab A/S
77 funds declare 108 bond lines of this company; the 25 largest holdings follow. The amount is the one filed, never a share of the debt: no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Funds holding Genmab A/S". https://titelia.com/en/stocks/genmab-a-s-US3723032062